Skip to main content
Erschienen in: Supportive Care in Cancer 11/2004

01.11.2004 | Original Article

Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey

verfasst von: G. Nagel, H. Hoyer, D. Katenkamp

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2004

Einloggen, um Zugang zu erhalten

Abstract

Goals of the work

The aim of this study was to assess the period prevalence and identify predictors of the use of complementary and alternative medicine (CAM) among women with breast cancer.

Patients and methods

In a cross-sectional study, 263 women participating in a quality of life survey reported on CAM use. Differences between CAM users and nonusers were evaluated using logistic regression.

Results

About 3 years after diagnosis the period prevalence of CAM use among women with breast cancer was 36%. Younger women reported usage of CAM more often than older women. Associations between remote disease, pain and psychosocial variables were found. Involvement in self-help groups and active participation in leisure activities were associated with CAM use; this may indicate differences in the patients’ ability to cope with the disease. Most patients were informed of CAM by a physician.

Conclusions

Involvement in self-help groups and leisure activities were associated with CAM use, indicating differences in the patients’ ability to cope. Further research is necessary to evaluate the safety of CAM and to determine the value of CAM in health care.
Literatur
1.
Zurück zum Zitat Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter—a qualitative study in women with breast cancer. J Fam Pract 48:453–458PubMed Adler SR, Fosket JR (1999) Disclosing complementary and alternative medicine use in the medical encounter—a qualitative study in women with breast cancer. J Fam Pract 48:453–458PubMed
2.
Zurück zum Zitat Bloom JR, Stewart SL, Johnston M, Blanks P (1998) Intrusiveness of illness and quality of life on young women with breast cancer. Psychooncology 7:89–100CrossRefPubMed Bloom JR, Stewart SL, Johnston M, Blanks P (1998) Intrusiveness of illness and quality of life on young women with breast cancer. Psychooncology 7:89–100CrossRefPubMed
3.
Zurück zum Zitat Boon H, Stewart M, Kennard MA, et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario. Prevalence and perceptions. J Clin Oncol 18:2515–2521PubMed Boon H, Stewart M, Kennard MA, et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario. Prevalence and perceptions. J Clin Oncol 18:2515–2521PubMed
4.
Zurück zum Zitat Burstein HJ, Gelber S, Guadagnoli E, et al (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733–1739CrossRefPubMed Burstein HJ, Gelber S, Guadagnoli E, et al (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733–1739CrossRefPubMed
5.
Zurück zum Zitat Cassileth BR (1999) Complementary and alternative cancer medicine. J Clin Oncol 17 (11s):44–52 Cassileth BR (1999) Complementary and alternative cancer medicine. J Clin Oncol 17 (11s):44–52
6.
Zurück zum Zitat Crocetti E, Crotti N, Montella M, Musso MI (1996) Complementary medicine and oncologists attitudes. A survey in Italy. Tumori 82:539–542PubMed Crocetti E, Crotti N, Montella M, Musso MI (1996) Complementary medicine and oncologists attitudes. A survey in Italy. Tumori 82:539–542PubMed
7.
Zurück zum Zitat Downer SM, Cody MM, McCluskey P, et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309:86–89PubMed Downer SM, Cody MM, McCluskey P, et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309:86–89PubMed
8.
Zurück zum Zitat Durant JR (1998) Alternative medicine: an attractive nuisance. J Clin Oncol 16:1–2PubMed Durant JR (1998) Alternative medicine: an attractive nuisance. J Clin Oncol 16:1–2PubMed
9.
Zurück zum Zitat Eisenberg DM (1997) Advising patients who seek alternative medical therapies. Ann Intern Med 127:61–69PubMed Eisenberg DM (1997) Advising patients who seek alternative medical therapies. Ann Intern Med 127:61–69PubMed
10.
Zurück zum Zitat Eisenberg DM, Kessler RC, Forster C, Norlock FE, Calkins DR, Deldano TL (1993) Unconventional medicine in the United States. Prevalence, costs and pattern of use. N Engl J Med 328:246–252CrossRefPubMed Eisenberg DM, Kessler RC, Forster C, Norlock FE, Calkins DR, Deldano TL (1993) Unconventional medicine in the United States. Prevalence, costs and pattern of use. N Engl J Med 328:246–252CrossRefPubMed
11.
Zurück zum Zitat Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575CrossRefPubMed Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575CrossRefPubMed
12.
Zurück zum Zitat Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer. A systematic review. Cancer 83:777–782 Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer. A systematic review. Cancer 83:777–782
13.
Zurück zum Zitat Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky M, Petersen L (1996) Breast cancer survivors. Psychosocial concerns and quality of life. Breast Cancer Res Treat 38:183–199PubMed Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky M, Petersen L (1996) Breast cancer survivors. Psychosocial concerns and quality of life. Breast Cancer Res Treat 38:183–199PubMed
14.
Zurück zum Zitat Hosmer DW, Lemeshaw S (2000) Applied logistic regression, 2nd edn. John Wiley & Sons, New York Hosmer DW, Lemeshaw S (2000) Applied logistic regression, 2nd edn. John Wiley & Sons, New York
15.
Zurück zum Zitat International Union against Cancer (UICC) (1997) TNM classification of malignant tumours, 5th edn. John Wiley & Sons, New York International Union against Cancer (UICC) (1997) TNM classification of malignant tumours, 5th edn. John Wiley & Sons, New York
16.
Zurück zum Zitat Koller M, Heitmann K, Kussmann J, Lorenz W (1999) Symptom reporting in cancer patients II. Relations to social desirability, negative affect and self-reported health behaviors. Cancer 86:1609–1620 Koller M, Heitmann K, Kussmann J, Lorenz W (1999) Symptom reporting in cancer patients II. Relations to social desirability, negative affect and self-reported health behaviors. Cancer 86:1609–1620
17.
Zurück zum Zitat Koller M, Lorenz W, Wagner K, Keil A, Trott D, Engenhart-Cabillic R, Nies C (2000) Expectations and quality of life of cancer patients undergoing radiotherapy. J R Soc Med 93:621–628PubMed Koller M, Lorenz W, Wagner K, Keil A, Trott D, Engenhart-Cabillic R, Nies C (2000) Expectations and quality of life of cancer patients undergoing radiotherapy. J R Soc Med 93:621–628PubMed
18.
Zurück zum Zitat Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg DM (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47CrossRefPubMed Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg DM (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47CrossRefPubMed
19.
Zurück zum Zitat Lerner IJ, Kennedey BJ (1992) The prevalence of questionable methods of cancer treatments in the United States. Cancer 42:181–191 Lerner IJ, Kennedey BJ (1992) The prevalence of questionable methods of cancer treatments in the United States. Cancer 42:181–191
20.
Zurück zum Zitat Moschèn R, Kemmler G, Schweigkofler H, et al (2001) Use of alternative/complementary therapy in breast cancer patients—a psychological perspective. Support Care Cancer 9:267–274CrossRefPubMed Moschèn R, Kemmler G, Schweigkofler H, et al (2001) Use of alternative/complementary therapy in breast cancer patients—a psychological perspective. Support Care Cancer 9:267–274CrossRefPubMed
21.
Zurück zum Zitat Munstedt K, Kirsch K, Milch W, et al (1996) Unconventional cancer therapy—survey of patients with gynaecological malignancy. Arch Gynecol Obstet 258:81–88CrossRefPubMed Munstedt K, Kirsch K, Milch W, et al (1996) Unconventional cancer therapy—survey of patients with gynaecological malignancy. Arch Gynecol Obstet 258:81–88CrossRefPubMed
22.
Zurück zum Zitat Munstedt K, Entezami A, Wartenberg A, Kullmer U (2000) The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT). Eur J Cancer 36:2090–2095 Munstedt K, Entezami A, Wartenberg A, Kullmer U (2000) The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT). Eur J Cancer 36:2090–2095
23.
Zurück zum Zitat Nagel G, Schmidt S, Strauss B, Katenkamp D (2001) Quality of life in breast cancer patients. A cluster analytic approach. Empirically derived subgroups of the EORTC-QLQ-BR23—a clinically oriented assessment. Breast Cancer Res Treat 68:75–87CrossRefPubMed Nagel G, Schmidt S, Strauss B, Katenkamp D (2001) Quality of life in breast cancer patients. A cluster analytic approach. Empirically derived subgroups of the EORTC-QLQ-BR23—a clinically oriented assessment. Breast Cancer Res Treat 68:75–87CrossRefPubMed
24.
Zurück zum Zitat Redler-Hasford E, van Eimern W, Tritschler J (1985) Warum sind Krebspatienten aufgeschlossen für unkonventionelle Behandlungsmethoden? Erfahrungsheilkunde 759–769 Redler-Hasford E, van Eimern W, Tritschler J (1985) Warum sind Krebspatienten aufgeschlossen für unkonventionelle Behandlungsmethoden? Erfahrungsheilkunde 759–769
25.
Zurück zum Zitat Rees RW, Feigel I, Vickers A, Zollmann C, McGurk R, Smith C (2000) Prevalence of complementary therapy use by women with breast cancer. A population-based survey. Eur J Cancer 36:1359–1364 Rees RW, Feigel I, Vickers A, Zollmann C, McGurk R, Smith C (2000) Prevalence of complementary therapy use by women with breast cancer. A population-based survey. Eur J Cancer 36:1359–1364
26.
Zurück zum Zitat Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMed Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMed
27.
Zurück zum Zitat Söllner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance but with active coping behaviour. Cancer 89:873–880 Söllner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance but with active coping behaviour. Cancer 89:873–880
29.
Zurück zum Zitat Weis J, Bartsch H, Hennies F, et al (1998) Complementary medicine in cancer patients. Demands, patient’s attitude and psychological belief. Onkologie 21:144–149CrossRef Weis J, Bartsch H, Hennies F, et al (1998) Complementary medicine in cancer patients. Demands, patient’s attitude and psychological belief. Onkologie 21:144–149CrossRef
30.
Zurück zum Zitat Zollman C, Vickers A (1999) ABC of complementary medicine. Complementary medicine and the doctor. BMJ 319:1558–1561PubMed Zollman C, Vickers A (1999) ABC of complementary medicine. Complementary medicine and the doctor. BMJ 319:1558–1561PubMed
Metadaten
Titel
Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey
verfasst von
G. Nagel
H. Hoyer
D. Katenkamp
Publikationsdatum
01.11.2004
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2004
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0675-5

Weitere Artikel der Ausgabe 11/2004

Supportive Care in Cancer 11/2004 Zur Ausgabe

Forthcoming Meetings

November 2004

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.